Dr. Altman is an Internal Medicine physician, sub-specializing in Infectious Diseases. Her research focuses on Staphylococcus aureus (S. aureus) pathogenesis, epidemiology, and genomics. She began her study of S. aureus during Internal Medicine residency at New York University and carried her work to fellowship in Infectious Diseases at the Icahn School of Medicine at Mount Sinai, where she investigates the capabilities of genomics to delineate both intra- and inter-host adaptation. She is the initiator and Project Lead of the collaborative Pathogen Surveillance Program (PSP) which uses genomics to define bacterial diversity at the Mount Sinai Health System.
Language
English
Position
ASSOCIATE PROFESSOR | Medicine, Infectious Diseases, ASSOCIATE PROFESSOR | Genetics and Genomic Sciences
Dr. Altman is an Internal Medicine physician, sub-specializing in Infectious Diseases. Her research focuses on Staphylococcus aureus (S. aureus) pathogenesis, epidemiology, and genomics. She began her study of S. aureus during Internal Medicine residency at New York University and carried her work to fellowship in Infectious Diseases at the Icahn School of Medicine at Mount Sinai, where she investigates the capabilities of genomics to delineate both intra- and inter-host adaptation. She is the initiator and Project Lead of the collaborative Pathogen Surveillance Program (PSP) which uses genomics to define bacterial diversity at the Mount Sinai Health System.
Language
English
Position
ASSOCIATE PROFESSOR | Medicine, Infectious Diseases, ASSOCIATE PROFESSOR | Genetics and Genomic Sciences
Dr. Altman is an Internal Medicine physician, sub-specializing in Infectious Diseases. Her research focuses on Staphylococcus aureus (S. aureus) pathogenesis, epidemiology, and genomics. She began her study of S. aureus during Internal Medicine residency at New York University and carried her work to fellowship in Infectious Diseases at the Icahn School of Medicine at Mount Sinai, where she investigates the capabilities of genomics to delineate both intra- and inter-host adaptation. She is the initiator and Project Lead of the collaborative Pathogen Surveillance Program (PSP) which uses genomics to define bacterial diversity at the Mount Sinai Health System.
Language
English
Position
ASSOCIATE PROFESSOR | Medicine, Infectious Diseases, ASSOCIATE PROFESSOR | Genetics and Genomic Sciences
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai physician communicated with them during an office visit. The Star Rating is based on patient responses to three questions on the Clinician & Group CAHPS (CG-CAHPS) Survey, a standardized questionnaire developed by Medicare. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Explains in a way you understand
4.9 out of 5
Listens carefully
5 out of 5
Likelihood to recommend
4.9 out of 5
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Altman did not report having any of the following types of financial relationships with industry during 2021 and/or 2022: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
